We always have something going on at Juno.
Want to keep up with our most recent developments?
Have a read of our latest news, new product launches and business news.
Filter News by:

Juno Launches New Range of Polypropylene Pre-Filled Syringes

Juno is pleased to announce the launch of their new range of polypropylene pre-filled syringes, supplied by Aguettant, a leading French manufacturer of injectable medicines. Read more

Juno Pharmaceuticals $30,000 Emerging Researcher Grant

Juno’s support of the Society of Hospital Pharmacists of Australia (SHPA) has today been strengthened, with the announcement of a new $30,000 research grant. The provision of this grant will provide up and coming Australian clinical pharmacists with an unprecedented opportunity to improve patient safety in the use of high-risk medicines. Read more

Amneal Portfolio Acquisition

Juno Pharmaceuticals today announced it has acquired the Amneal injectables, ophthalmic, and oncology portfolio. This business primarily has a focus on Australian hospital customers. Read more

Juno Pharmaceuticals appointed by Celgene Pty as Strategic Partner for its maturing brand Vidaza® (5-azacitidine) in Australia

MELBOURNE, AUSTRALIA–Celgene Pty Ltd and Juno Pharmaceuticals Pty Ltd today announced the signing of a definitive agreement in which Celgene has appointed Juno as its strategic partner for its maturing brand – Vidaza® in Australia. Read more

Juno Appointed Exclusive Distributor for Hexvix®

Juno Pharmaceuticals is excited to announced it has been appointed as the exclusive distributor in Australia and New Zealand for Hexvix® (hexaminolevulinate hydro-chloride), an innovative breakthrough technology to aid in the diagnosis and management of non-muscle-invasive bladder cancer. The registration process will begin immediately with hopes that this product will be registered in 2016. Read more